Annexon Inc. Shares Dip 1.57% – Market Capitalization Hits $710.9 M
Annexon Inc. (ANNX) drops 1.57% amid market volatility; biotech focus on autoimmune & neurodegenerative therapies offers long‑term upside above $5.27 MA.
3 minutes to read
ANNEXON INC
Annexon Inc. Slides 4.5% in Mid‑Week Trading Amid Strong Pipeline Potential
Annexon Inc. drops 4.5% amid market volatility, but its strong pipeline for autoimmune and neurodegenerative therapies and strategic pharma partnerships suggest future upside.
3 minutes to read